KOD Kodiak Sciences Inc.
Nasdaq · SEC CIK 1468748 · EDGAR
- Bought, last 12 months
- $60.00M 1 purchases by 1 insiders
- Sold, last 12 months
- $2.22M 2 sales by 1 insiders
- Filings on record
- 90 since 2021-07-02, latest 2026-07-17 16:40
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Baker Brothers Life Sciences LP | Dir, 10% | $60.00M | — |
| BORGESON JOHN A. | CFO | — | $2.22M |
| PERLROTH VICTOR | COB, CEO, Dir | — | — |
Transactions 53
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-05 17:56 | 2026-06-04 | KOD | BORGESON JOHN A. | CFO | M - OptEx | $1.04 | +30.0K | 241.9K | +14% | +$31.2K |
| DMT | 2026-06-05 17:56 | 2026-06-04 | KOD | BORGESON JOHN A. | CFO | S - Sale+OE | $34.10 | -30.0K | 211.9K | -12% | -$1.02M |
| D | 2026-04-16 17:00 | 2026-04-15 | KOD | BORGESON JOHN A. | CFO | M - OptEx | $1.04 | +28.6K | 211.9K | +16% | +$29.8K |
| DT | 2026-04-02 20:26 | 2026-04-02 | KOD | BORGESON JOHN A. | CFO | M - OptEx | $1.04 | +30.0K | 213.3K | +16% | +$31.2K |
| DMT | 2026-04-02 20:26 | 2026-04-02 | KOD | BORGESON JOHN A. | CFO | S - Sale+OE | $39.92 | -30.0K | 183.3K | -14% | -$1.20M |
| D | 2026-03-27 | 2026-03-25 | KOD | PERLROTH VICTOR | COB, CEO, Dir | M - OptEx | $1.04 | +300.0K | 2.40M | +14% | +$312.0K |
| MI | 2025-12-19 | 2025-12-18 | KOD | Baker Brothers Life Sciences LP | Dir, 10% | P - Purchase | $23.00 | +2.61M | 18.36M | +17% | +$60.00M |
| D | 2025-06-17 | 2025-06-17 | KOD | BORGESON JOHN A. | See Remarks | S - Sale+OE | $3.65 | -723 | 183.3K | -0.4% | -$2,639 |
| D | 2025-06-17 | 2025-06-15 | KOD | BORGESON JOHN A. | See Remarks | M - OptEx | — | +1,875 | 184.0K | +1% | — |
| D | 2024-06-18 | 2024-06-17 | KOD | BORGESON JOHN A. | See Remarks | S - Sale+OE | $2.75 | -2,874 | 182.2K | -2% | -$7,904 |
| D | 2024-06-18 | 2024-06-15 | KOD | BORGESON JOHN A. | See Remarks | M - OptEx | — | +5,494 | 185.0K | +3% | — |
| D | 2024-06-13 | 2024-06-11 | KOD | BORGESON JOHN A. | See Remarks | M - OptEx | — | +3,025 | 181.1K | +2% | — |
| D | 2024-06-13 | 2024-06-12 | KOD | BORGESON JOHN A. | See Remarks | S - Sale+OE | $2.92 | -1,558 | 179.5K | -0.9% | -$4,549 |
| DM | 2023-06-16 | 2023-06-14+ | KOD | BORGESON JOHN A. | See Remarks | S - Sale+OE | $9.30 | -4,197 | 178.1K | -2% | -$39.0K |
| D | 2023-06-16 | 2023-06-15 | KOD | BORGESON JOHN A. | See Remarks | M - OptEx | — | +5,494 | 180.8K | +3% | — |
| DM | 2023-06-16 | 2023-06-14+ | KOD | EHRLICH JASON | See Remarks | S - Sale+OE | $9.29 | -3,390 | 61.9K | -5% | -$31.5K |
| D | 2023-06-16 | 2023-06-15 | KOD | EHRLICH JASON | See Remarks | M - OptEx | — | +5,494 | 64.2K | +9% | — |
| D | 2023-06-13 | 2023-06-11 | KOD | EHRLICH JASON | See Remarks | M - OptEx | — | +2,900 | 59.8K | +5% | — |
| D | 2023-06-13 | 2023-06-11 | KOD | BORGESON JOHN A. | See Remarks | M - OptEx | — | +3,025 | 176.8K | +2% | — |
| D | 2022-06-17 | 2022-06-15 | KOD | BORGESON JOHN A. | See Remarks | M - OptEx | — | +5,494 | 178.1K | +3% | — |
| DM | 2022-06-17 | 2022-06-15+ | KOD | BORGESON JOHN A. | See Remarks | S - Sale+OE | $7.09 | -4,343 | 176.6K | -2% | -$30.8K |
| DM | 2022-06-17 | 2022-06-15+ | KOD | EHRLICH JASON | See Remarks | S - Sale+OE | $7.09 | -3,487 | 56.9K | -6% | -$24.7K |
| D | 2022-06-17 | 2022-06-15 | KOD | EHRLICH JASON | See Remarks | M - OptEx | — | +5,494 | 60.4K | +10% | — |
| D | 2022-06-14 | 2022-06-11 | KOD | BORGESON JOHN A. | See Remarks | M - OptEx | — | +3,025 | 172.6K | +2% | — |
| D | 2022-06-14 | 2022-06-11 | KOD | EHRLICH JASON | See Remarks | M - OptEx | — | +2,900 | 54.9K | +6% | — |
| MI | 2022-06-06 | 2022-06-02+ | KOD | Baker Bros. Advisors (GP) LLC | Dir, 10% | P - Purchase | $7.77 | +572.3K | 1.34M | +74% | +$4.45M |
| MI | 2022-05-27 | 2022-05-25+ | KOD | BAKER FELIX | Dir, 10% | P - Purchase | $6.74 | +350.4K | 1.25M | +39% | +$2.36M |
| MI | 2022-05-18 | 2022-05-16+ | KOD | Baker Brothers Life Sciences LP | Dir, 10% | P - Purchase | $5.91 | +456.7K | 1.25M | +58% | +$2.70M |
| M | 2022-02-28 | 2022-02-24+ | KOD | PERLROTH VICTOR | COB, CEO, Dir, 10% | S - Sale | $9.15 | -1.34M | 2.17M | -38% | -$12.26M |
| MI | 2022-02-17 | 2022-02-15+ | KOD | Baker Brothers Life Sciences LP | Dir, 10% | P - Purchase | $54.45 | +401.0K | 14.46M | +3% | +$21.83M |
| MI | 2022-01-31 | 2022-01-27+ | KOD | BAKER BROS. ADVISORS LP | Dir, 10% | P - Purchase | $52.02 | +347.7K | 1.16M | +43% | +$18.08M |
| MI | 2022-01-25 | 2022-01-21+ | KOD | BAKER FELIX | Dir, 10% | P - Purchase | $57.49 | +501.1K | 13.96M | +4% | +$28.81M |
| D | 2022-01-24 | 2022-01-20 | KOD | EHRLICH JASON | See Remarks | M - OptEx | $10.29 | +6,950 | 58.5K | +13% | +$71.5K |
| DM | 2022-01-24 | 2022-01-20 | KOD | EHRLICH JASON | See Remarks | S - Sale+OE | $64.38 | -6,950 | 55.3K | -11% | -$447.5K |
| DM | 2021-12-22 | 2021-12-20 | KOD | EHRLICH JASON | See Remarks | S - Sale+OE | $87.60 | -6,950 | 51.5K | -12% | -$608.8K |
| D | 2021-12-22 | 2021-12-20 | KOD | EHRLICH JASON | See Remarks | M - OptEx | $10.29 | +6,950 | 58.5K | +13% | +$71.5K |
| D | 2021-11-24 | 2021-11-22 | KOD | EHRLICH JASON | See Remarks | M - OptEx | $10.29 | +6,950 | 58.5K | +13% | +$71.5K |
| DM | 2021-11-24 | 2021-11-22 | KOD | EHRLICH JASON | See Remarks | S - Sale+OE | $99.15 | -6,950 | 54.6K | -11% | -$689.1K |
| M | 2021-11-12 | 2021-11-10 | KOD | BORGESON JOHN A. | See Remarks | S - Sale | $115.42 | -876 | 169.4K | -0.5% | -$101.1K |
| D | 2021-10-22 | 2021-10-20 | KOD | EHRLICH JASON | See Remarks | M - OptEx | $10.29 | +6,950 | 58.5K | +13% | +$71.5K |
| DM | 2021-10-22 | 2021-10-20 | KOD | EHRLICH JASON | See Remarks | S - Sale+OE | $111.77 | -6,950 | 52.8K | -12% | -$776.8K |
| DMI | 2021-10-01 | 2021-09-29 | KOD | BAKER BROS. ADVISORS LP | Dir, 10% | M - OptEx | $0.01 | +150.0K | 13.44M | +1% | +$1,500 |
| DMI | 2021-10-01 | 2021-09-29 | KOD | BAKER BROS. ADVISORS LP | Dir, 10% | F - Tax | $102.00 | -16 | 13.44M | -0.0% | -$1,632 |
| DI | 2021-10-01 | 2021-09-30 | KOD | BAKER BROS. ADVISORS LP | Dir, 10% | P - Purchase | $95.83 | +86.9K | 13.53M | +0.6% | +$8.33M |
| D | 2021-09-22 | 2021-09-20 | KOD | EHRLICH JASON | See Remarks | M - OptEx | $10.29 | +6,950 | 58.5K | +13% | +$71.5K |
| DM | 2021-09-22 | 2021-09-20 | KOD | EHRLICH JASON | See Remarks | S - Sale+OE | $99.88 | -6,950 | 52.4K | -12% | -$694.1K |
| MI | 2021-09-17 | 2021-09-15+ | KOD | Baker Brothers Life Sciences LP | Dir, 10% | P - Purchase | $94.39 | +31.8K | 13.30M | +0.2% | +$3.01M |
| MI | 2021-09-09 | 2021-09-07 | KOD | Baker Bros. Advisors (GP) LLC | Dir, 10% | P - Purchase | $93.31 | +57.5K | 13.27M | +0.4% | +$5.37M |
| DM | 2021-08-24 | 2021-08-20 | KOD | EHRLICH JASON | See Remarks | S - Sale+OE | $91.45 | -6,950 | 57.0K | -11% | -$635.5K |
| D | 2021-08-24 | 2021-08-20 | KOD | EHRLICH JASON | See Remarks | M - OptEx | $10.29 | +5,258 | 58.5K | +10% | +$54.1K |
| MI | 2021-08-19 | 2021-08-17+ | KOD | 667, L.P. | Dir, 10% | P - Purchase | $87.50 | +114.4K | 13.14M | +0.9% | +$10.01M |
| MI | 2021-08-13 | 2021-08-11+ | KOD | Baker Bros. Advisors (GP) LLC | Dir, 10% | P - Purchase | $87.19 | +102.8K | 13.00M | +0.8% | +$8.96M |
| M | 2021-07-22 | 2021-07-20 | KOD | EHRLICH JASON | See Remarks | S - Sale | $86.28 | -6,950 | 57.9K | -11% | -$599.6K |
Purchase Sale Sale after option exercise All abbreviations